TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
INSM

Insmed Inc

Healthcare · Biotechnology

120.80$ -0.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Insmed Inc (INSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,103 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INSM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,325 1,330 1,159 1,810 2,053 2,025 1,803 2,480 2,361 2,265 2,076 2,103
927 929 759 1,418 1,650 1,622 1,403 2,082 1,932 1,794 1,613 1,634
487 482 596 1,247 461 555 403 1,284 335 510 582 545
786 780 596 1,247 1,468 1,434 1,199 1,857 1,680 1,430 1,224 1,160
36 41 37 40 42 52 48 55 65 141 179 215
78 83 83 90 98 99 101 108 121 132 133 142
136 136 136 136 136 136 136 136 136 136 136 136
65 64 62 61 60 59 57 56 85 98 96 93
1,614 1,662 1,624 1,771 1,570 1,740 1,704 1,230 1,415 1,526 1,371 1,345
197 226 421 524 259 298 239 312 417 469 361 439
8.9 14 235 237 14 16 10 11 12 19 14 9.8
65 65 44 51 65 73 58 74 80 80 73 429
1,148 1,155 939 947 955 1,103 1,105 539 540 541 542 544
-289 -332 -465 39 483 285 99 1,250 946 739 705 757
-3,260 -3,446 -3,603 -3,904 -4,124 -4,360 -4,617 -4,938 -5,308 -5,637 -5,800 -5,813
143 145 148 155 174 179 181 189 211 214 215 217

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?